SIM
IART icon

SummerHaven Investment Management’s Integra LifeSciences IART Stock Holding History

SummerHaven Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$497K Sell
52,789
-11,978
-18% -$132K 0.31% 173
2025
Q4 		$804K Hold
64,767
– – 0.46% 126
2025
Q3 		$928K Buy
+64,767
New +$887K 0.54% 62

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SummerHaven Investment Management's IART Position: Q1 2026 in Review

SummerHaven Investment Management reduced its Integra LifeSciences (IART) stake by 18% in Q1 2026, selling an estimated $132K and leaving 52,789 shares worth $497K. The position accounts for 0.31% of the portfolio, ranked #173.

SummerHaven Investment Management first reported a position in IART in Q3 2025 and has held it in 3 quarters since. The position peaked at $928K in Q3 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • SummerHaven Investment Management held 52,789 shares of Integra LifeSciences worth $497K as of Q1 2026.
  • SummerHaven Investment Management sold 11,978 Integra LifeSciences shares in Q1 2026, an estimated $132K.
  • Integra LifeSciences made up 0.31% of SummerHaven Investment Management's portfolio in Q1 2026, its #173 holding.
  • SummerHaven Investment Management first reported a position in Integra LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • SummerHaven Investment Management's Integra LifeSciences position peaked at $928K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on SummerHaven Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.